Evaluation of lung immune response to the BNT162b2 COVID-19 vaccine
D. Padawer (Jerusalem, Israel), M. Stolovich-Rain (Jerusalem, Israel), M. Billan (Jerusalem, Israel), N. Berkman (Jerusalem, Israel), A. Rouvinski (Jerusalem, Israel)
Source: International Congress 2022 – Vaccination
Session: Vaccination
Session type: Thematic Poster
Number: 1127
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Padawer (Jerusalem, Israel), M. Stolovich-Rain (Jerusalem, Israel), M. Billan (Jerusalem, Israel), N. Berkman (Jerusalem, Israel), A. Rouvinski (Jerusalem, Israel). Evaluation of lung immune response to the BNT162b2 COVID-19 vaccine. 1127
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|